Friday, January 18, 2013

Cell Culture :MarketResearchReports.biz

GBI Research, the leading business intelligence provider, has
released its latest research “Cell Culture Rising Demand for Biologics
and Growing Visibility of Approval Pathway for Biosimilars will Create
Growth Opportunities”, which provides in-depth analysis on the
processes, drivers and barriers of the cell culture market. The report
analyzes the role of biopharmaceutical products that basically provide
enhancement to media, sera, reagents and cell culture market. Major
manufacturing technologies involved in the cell culture technology have
been detailed in the report. Furthermore, the report provides
competitive benchmarking for the leading players that shape the global
media, sera, reagent and overall cell culture market.

This report is built using data and information sourced from
proprietary databases, primary and secondary research and in-house
analysis by GBI Research’s team of industry experts.

Cell culture technology is used to carry out processes external to
the natural environment by maintaining controlled environments which
enable the growth of various cell cultures for use in medicine and
research. The processes is related to methods involved in the
development of tissue or organ cultures. Multicellular eukaryotic cells
from animals are usually preferred for cell culture as they provide
standard characteristics for growing environments. Plant cells are the
second choice for culture technology, while fungi, bacteria, protists
and others are also used for the developmental process.

The development of recombinant methods involves genetic
manipulation and restructuring of DNA or genes. Genetic recombination
usually takes place in a biological environment, while DNA recombination
occurs either during a repair response or experiments using in vitro
studies. This is also known as genetic engineering technology and was
developed at the end of the twentieth century. This method was further
developed for large-scale cell culture production and was found to be
helpful in protein synthesis processes, such as insulin production.

GBI Research indicates that the cell culture market is growing
continuously due to increased demand for biopharmaceutical products. The
introduction of biosimilars across various geographies in the forecast
period on a large scale will boost the cell culture market, rapidly.
Despite concerns about low flexibility for manufacturing quantities and
other factors, the higher efficacy of the end products will drive its
growth in the future.

Scope

Analysis of various technologies involved in cell culture and the key associated manufacturing processes involved

Key drivers and barriers that have a significant impact on the cell culture market.

Major equipment, cell banks and cell lines for cell culture development have been analyzed

Annualized market data for the media, sera, reagents and global cell
culture market from 2004 to 2011, forecast forward to 2018, have been
provided in the report.

Major players in the cell culture market are enlisted providing their company overview and company roles in the market.

Reasons to buy

Align your product portfolio to the markets with high growth potential

Develop market-entry and market expansion strategies by identifying
the leading therapeutic segments and geographic markets poised for
strong growth

Develop strategic initiatives by understanding the key focus areas of leading companies

Exploit in-licensing and out-licensing opportunities by identifying products that could fill portfolio gaps